Built for commercial, medical, regulatory, and strategy teams, our analytics-driven CI model combines domain expertise with intelligent automation to deliver focused, contextual, and action-ready insights.
Our hybrid model goes beyond tracking competitor activity, it provides strategic implications and “so-what” insights that help commercial, medical, and regulatory teams make smarter, faster decisions.
Our CI framework is designed to support proactive strategy-building, risk anticipation, and confident decision-making. The hybrid CI model brings together human expertise and intelligent automation to deliver real-time, implication-first insights. Designed to scale across geographies, therapy areas, and functions, without compromising interpretation quality or speed.
Our model doesn’t just surface updates, it distills what matters and why it matters. Whether you’re preparing for launch, tracking competitor pipelines, or identifying early market signals, our CI offering powers smarter, faster decisions.
Chryselys CI integrates real-time monitoring, expert analysis, and scalable intelligence delivery to move beyond “what happened” and focus on “what this means for you.”
Automated tracking of clinical trials, IR updates, patents, congress coverage, regulatory shifts, and more ensuring you never miss a critical move.
Our CI specialists contextualize every signal – clinical, commercial, or policy, to extract strategic implications, not just trends.
Easily tailored by therapy area, market, or business function, our model flexes to your priorities without compromising quality.
Live dashboards, curated newsletters, and on-demand compendiums make intelligence accessible across the organization.
Our experienced CI analysts decode clinical, regulatory, and commercial signals, translating them into actionable recommendations.
Automated scanning of trials, news, investor calls, congresses, publications, and patents, ensuring nothing is missed.
From curated newsletters and live dashboards to compendiums and trackers, our CI hubs drive higher engagement and better decisions.
Automation to cut noise. Experts to ensure relevance.
Every insight comes with a “what next,” tailored to your priorities.
Expandable across therapy areas, markets, and portfolios without stretching teams thin.
More engagement. Faster decisions. Higher value from every CI dollar spent.
Inform defence strategies, competitive positioning, and LCM opportunities.
Align trial tracking and evidence strategy with timely, contextual insights.
At Chryselys, we understand the value of data-led decision making. By equipping our partners with intelligent.
Use early-warning intelligence to inform investment decisions and portfolio moves.
(Customizable by TA/region)
From supporting launch defence planning to shaping market access strategies, our CI solutions are already influencing key decisions at global pharma organizations. Clients report higher newsletter readership, greater use in decision forums, and increased inbound insight requests from brand teams.
Discover KYRA – Clinical for trial-level insights and KYRA – Commercial for commercialization strategies built on real-time signals.
Revolutionize your business trajectory and achieve unprecedented growth with our committed partnership
